Cargando…
Aspartoacylase suppresses prostate cancer progression by blocking LYN activation
BACKGROUND: Globally, despite prostate cancer (PCa) representing second most prevalent malignancy in male, the precise molecular mechanisms implicated in its pathogenesis remain unclear. Consequently, elucidating the key molecular regulators that govern disease progression could substantially contri...
Autores principales: | Weng, Hong, Xiong, Kang-Ping, Wang, Wang, Qian, Kai-Yu, Yuan, Shuai, Wang, Gang, Yu, Fang, Luo, Jun, Lu, Meng-Xin, Yang, Zhong-Hua, Liu, Tao, Huang, Xing, Zheng, Hang, Wang, Xing-Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240701/ https://www.ncbi.nlm.nih.gov/pubmed/37271807 http://dx.doi.org/10.1186/s40779-023-00460-0 |
Ejemplares similares
-
Involvement of aspartoacylase in tremor expression in rats
por: Nishitani, Ai, et al.
Publicado: (2016) -
Mapping the degradation pathway of a disease-linked aspartoacylase variant
por: Gersing, Sarah K., et al.
Publicado: (2021) -
A Novel Mutation in Aspartoacylase Gene; Canavan Disease
por: ASHRAFI, Mahmoudreza, et al.
Publicado: (2015) -
Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer
por: Han, Yalin, et al.
Publicado: (2023) -
Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival
por: Gautier, Emmanuel L., et al.
Publicado: (2014)